America writes more than 4 billion drug prescriptions every year. And according to the research, 50% of them aren't working. To start, that's an incredible waste of money. America's healthcare tab is ...

Aware of this aspect, the pharmaceutical industry has recently started to implement pharmacogenomics into the drug-development pipeline by correlating quantitative measures derived from ...

With any prognosis, pharmacogenomics can support physicians with accurately selecting treatments for patients based on the patient’s unique genomic profile. Leveraging that patient’s genomic profile ...

Clinical trials offer a slew of benefits: optimal dosage ranges, identified potential side effects, and efficacy data. If approved by the FDA, clinicians leverage the insights from Phase III trials to ...

Pharmacogenomics is a tool that can assist providers in optimizing drug selection and dosing, help avoid costly adverse effects, and identify responders and non-responders to medications. New and ...

SAN FRANCISCO (KGO) -- The way patients are prescribed medicine could soon be a lot more precise. A new form of testing by UCSF could help determine how a patient's body will respond to specific ...

UPMC doctors are piloting a new program to administer gene tests to patients to determine whether they are likely to respond to medications. For example, a simple blood test can determine whether a ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Precision medicine’s promise is to determine for each individual ...

Pharmacogenomics is the field of study about the effect of genes on an individual’s response to medications. It combines the science of drugs, which is known as pharmacology, with the study of genes, ...

The human body is marvellously complex and so is the science of treatment. Today, the field of medicine has become ever more targeted and specialised, with pharmacogenomics providing greater insights ...

Several pharmacogenetic tests have been developed, representing tangible deliverables of the numerous genomic studies to correlate genetic variation with variable drug response. A handful of these ...